Cat. No. 3531
Chemical Name: 4-(5H-Dibenzo[a,d]cyclohepten-5-yli
Biological ActivityOrally active inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS) (Ki = 75 μM, IC50 = 95 μM). Inhibits the production of PGD2 from PGH2 in vitro, with no effect on PGE2 or PGF2α production.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Irikura et al (2009) Biochemical, functional and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase. J.Biol.Chem. 284 7623. PMID: 19131342.
If you know of a relevant reference for AT 56 please let us know.
Citations are publications that use Tocris products. Selected citations for AT 56 include:
Jaurena et al (2015) Zic1 controls placode progenitor formation non-cell autonomously by regulating retinoic acid production and transport. Elife 6 7476. PMID: 26101153.
Do you know of a great paper that uses AT 56 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: AT 56, supplier, AT56, L-PGDS, lipocalin-type, prostaglandin, PG, D, synthase, inhibitors, inhibits, Tocris Bioscience, Other Synthase/Synthetase Inhibitor products